The Department of Defense (DoD) is offering the Peer Reviewed Medical Research Program (PRMRP) Clinical Trial Award to support the swift execution of clinical trials. This grant aims to significantly impact the treatment or management of diseases and conditions specified within the FY25 PRMRP topic areas and strategic goals. This award mandates clinical trials, requiring rapid implementation. It’s crucial to note that animal studies are explicitly not allowed, and all preclinical work must be fully completed prior to the award start date. This initiative is designed to accelerate medical advancements through targeted human trials.
Opportunity ID: 358888
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | HT942525PRMRPCTA |
| Funding Opportunity Title: | DoD Peer Reviewed Medical Research Program, Clinical Trial Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 4 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | May 09, 2025 |
| Last Updated Date: | May 09, 2025 |
| Original Closing Date for Applications: | Jul 21, 2025 |
| Current Closing Date for Applications: | Jul 21, 2025 |
| Archive Date: | Aug 20, 2025 |
| Estimated Total Program Funding: | $32,000,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: |
Summary: The fiscal year 2025 (FY25) Peer Reviewed Medical Research Program (PRMRP) Clinical Trial Award (CTA) supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of a disease or condition addressed in one of the congressionally directed FY25 PRMRP topic areas and FY25 PRMRP strategic goals. Distinctive Features: • Clinical trials are required. • Animal studies are NOT allowed under this award mechanism. All preclinical work must be completed prior to the award start date. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
CDMRP Help Desk
Phone: 301-682-5507 Email: help@eBRAP.org Email:help@eBRAP.org |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 358888 Full Announcement-FY25 PRMRP CTA -> HT942525PRMRPCTA-GG.pdf
Packages
| Agency Contact Information: | CDMRP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org Email: help@eBRAP.org |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.420 | PKG00290707 | May 09, 2025 | Jul 21, 2025 | View |
Package 1
Mandatory forms
358888 RR_SF424_5_0-5.0.pdf
358888 AttachmentForm_1_2-1.2.pdf
358888 RR_PersonalData_1_2-1.2.pdf
358888 RR_KeyPersonExpanded_4_0-4.0.pdf
358888 RR_Budget_3_0-3.0.pdf
358888 PerformanceSite_4_0-4.0.pdf
Optional forms
358888 RR_SubawardBudget30_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
